ATE171180T1 - Palau'amin: eine pharmakologisch aktive verbindung aus einem schwamm - Google Patents

Palau'amin: eine pharmakologisch aktive verbindung aus einem schwamm

Info

Publication number
ATE171180T1
ATE171180T1 AT94302770T AT94302770T ATE171180T1 AT E171180 T1 ATE171180 T1 AT E171180T1 AT 94302770 T AT94302770 T AT 94302770T AT 94302770 T AT94302770 T AT 94302770T AT E171180 T1 ATE171180 T1 AT E171180T1
Authority
AT
Austria
Prior art keywords
palau
sponge
amin
active compound
pharmacologically active
Prior art date
Application number
AT94302770T
Other languages
English (en)
Inventor
Robin Bryan Kinnel
Henning-Peter Gehrken
Paul Joseph Scheuer
Dolores Garcia Gravalos
Glynn Thomas Faircloth
Original Assignee
Pharma Mar Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharma Mar Sa filed Critical Pharma Mar Sa
Application granted granted Critical
Publication of ATE171180T1 publication Critical patent/ATE171180T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/22Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains four or more hetero rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10Antimycotics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/06Immunosuppressants, e.g. drugs for graft rejection

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Immunology (AREA)
  • Oncology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Communicable Diseases (AREA)
  • Transplantation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
AT94302770T 1993-04-20 1994-04-19 Palau'amin: eine pharmakologisch aktive verbindung aus einem schwamm ATE171180T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB939308111A GB9308111D0 (en) 1993-04-20 1993-04-20 Active compound from a stonge

Publications (1)

Publication Number Publication Date
ATE171180T1 true ATE171180T1 (de) 1998-10-15

Family

ID=10734127

Family Applications (1)

Application Number Title Priority Date Filing Date
AT94302770T ATE171180T1 (de) 1993-04-20 1994-04-19 Palau'amin: eine pharmakologisch aktive verbindung aus einem schwamm

Country Status (11)

Country Link
US (2) US20020062023A1 (de)
EP (1) EP0626383B1 (de)
JP (1) JP3489635B2 (de)
AT (1) ATE171180T1 (de)
AU (1) AU672098B2 (de)
CA (1) CA2121613A1 (de)
DE (1) DE69413302T2 (de)
DK (1) DK0626383T3 (de)
ES (1) ES2124844T3 (de)
GB (1) GB9308111D0 (de)
ZA (1) ZA942686B (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1152050C (zh) * 2001-07-12 2004-06-02 中国人民解放军第二军医大学 一种新的具有抗癌活性的环肽类化合物phakellistatin 12
US11332480B2 (en) 2017-04-27 2022-05-17 Pharma Mar, S.A. Antitumoral compounds
CN121045192B (zh) * 2025-08-26 2026-03-03 青岛大学 一类海绵来源吡咯咪唑生物碱二聚体的制备方法及应用

Also Published As

Publication number Publication date
GB9308111D0 (en) 1993-06-02
JP3489635B2 (ja) 2004-01-26
CA2121613A1 (en) 1994-10-21
US20020198379A1 (en) 2002-12-26
ES2124844T3 (es) 1999-02-16
DE69413302D1 (de) 1998-10-22
DK0626383T3 (da) 1999-06-14
EP0626383B1 (de) 1998-09-16
EP0626383A1 (de) 1994-11-30
ZA942686B (en) 1995-07-21
AU6059094A (en) 1994-10-27
DE69413302T2 (de) 1999-05-20
AU672098B2 (en) 1996-09-19
JPH07118274A (ja) 1995-05-09
US20020062023A1 (en) 2002-05-23

Similar Documents

Publication Publication Date Title
MA22014A1 (fr) Derives d'acides amines .
MX9702380A (es) Nuevas carboxamidas con actividad antifungica.
MX9702382A (es) Nuevos derivados de pirimidona con actividad antifungica.
DE60019693D1 (de) Pharmazeutische zusammensetzungen, die wirkstoffabsorptionsfördernde verbindungen enthalten
EE200300403A (et) N-asendatud mittearomaatne heterotsükliline ühend, seda sisaldav ravimkompositsioon ning ühendi kasutamine ravimina
DK0804252T3 (da) Monoamin-, diamid-, thiol-holdige metalchelateringsmidler
LU90366I2 (fr) Nasonex
SE9904508D0 (sv) New compounds
IL104891A0 (en) Cyclosporins,their preparation and pharmaceutical compositions containing them
BR0210122A (pt) Composto ou um sal farmaceuticamente aceitável do mesmo, método para o tratamento ou prevenção de uma doença, uso do composto ou de seu sal, e, método para preparar o mesmo
BR9812492A (pt) Composto, uso do mesmo, formulação farmacêutica, e, processos para o tratamento de uma doença cardiovascular, para o tratamento de uma vasoconstrição, e para a preparação de compostos
ATE321543T1 (de) Pharmazeutische zusammensetzungen mit hydroximsäurederivaten
WO2003022219A3 (en) Biarylamino purine antiproliferative agents
PT992509E (pt) Novos derivados macrolidos
ATE268337T1 (de) C11-carbamate von antibakteriellen makroliden
WO2003053971A8 (en) Pyridoquinoxaline antivirals
FI935800A0 (fi) Antidepressiva och mot Parkisons sjukdom verksamma foereningar
ATE166647T1 (de) Bis-naphthalimide für die behandlung von krebs
DE69413302D1 (de) Palau'amin: eine pharmakologisch aktive Verbindung aus einem Schwamm
ATE225787T1 (de) Arylsubstituierte heterocyclische verbindungen
DK0604355T3 (da) Arylsubstituerede heterocykliske forbindelser
KR970061248A (ko) 알츠하이머병 치료용 1, 1, 2-트리페닐부트-1-엔 유도체
CA2192822A1 (en) Use of immunosuppressive agents for the treatment of schizophrenia
MXPA05009763A (es) 2-(butil-1-sulfonilamino)-n-[1 (r)-(6-metoxipiridin-3-il) propil] benzamida, su uso en forma de un farmaco y preparaciones farmaceuticas que contienen a dicho compuesto.
PT1033132E (pt) Composicao de farmaco rapidamente soluvel

Legal Events

Date Code Title Description
REN Ceased due to non-payment of the annual fee